ArticlePhotochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology2026
Photodynamic treatment of glioblastoma plus endothelial cell spheroid models: increased proliferative and migratory aggressiveness of surviving tumor cells due to iNOS/NO upregulation.
Article in Photochemical & photobiological sciences : Official journal of the European Photochemistry Association and the European Society for Photobiology, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
Abstract
Photodynamic therapy (PDT) is a unique oxidative stress-based anti-tumor modality that has proven highly effective for various solid malignancies. Intrinsic and acquired resistance is a significant challenge for all cancer treatments, including PDT. We showed previously that several human cancer cell lines in 2D cultures can exploit nitric oxide (NO) from stress-upregulated inducible nitric oxide synthase (iNOS) to (i) resist photokilling sensitized by 5-aminolevulinic acid (ALA)-induced protoporphyrin IX, and (ii) promote growth and mobility aggressiveness of surviving tumor cells. We describe here a mixed-spheroid model consisting of glioblastoma (LN229 or U87) cells and normal human (HMEC-1) epithelial cells. To systematically investigate the interactions between tumor and endothelial cells in a 3D microenvironment, we developed a stepwise workflow: first, generating mixed spheroids with defined cell ratios; second, characterizing their growth, mechanical properties, and cellular organization using fluorescent labeling and confocal microscopy; third, assessing ALA-induced PpIX distribution and PDT efficacy; and finally, evaluating post-PDT responses including iNOS upregulation, proliferation, migration, and the impact of iNOS inhibition. Using high resolution confocal microscopy, we visualized the process of development of heterospheroid models. We analyzed the distribution of ALA-induced protoporphyrin IX within preformed spheroids. PpIX formed initially in the periphery of spheroid reaches even distribution within the spheroid in ~ 12 h of equilibration time. The survival of spheroid cells subjected to photodynamic action was determined. In general, higher doses of LED light were needed to achieve the same killing ratio for spheroids, as compared to 2D cultures. The effects of ALA/light treatment on the expression of iNOS, and proliferative potential of surviving tumor cells are reported. The impact of iNOS inhibitor (1400W) on the process of spheroid re-growth after induced photodynamic action was also analyzed. Photodynamic stress of glioma cells spheroids increases their intrinsic iNOS expression and NO-dependent proliferation. This increase is inversely proportional to the initial/constitutive expression of iNOS: less aggressive LN229 cells show greater stress-induced increase of iNOS and proliferation, than constitutively more aggressive U87 cells. The results presented suggest, that introduction of an iNOS inhibitor could significantly increase the effectiveness of photodynamic therapy.
Indexed as
Identifiers
42018124What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.